A prospective de-mri study evaluating the role of tgf-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: New insights into primary fibrotic atriocardiomyopathy

Journal of Cardiovascular Electrophysiology

Volumn 26, Issue 3, 2015, Pages 251-259

  Canpolat, Uʇur ^a   Oto, Ali ^a   Hazirolan, Tuncay ^a   Sunman, Hamza ^a   Yorgun, Hikmet ^a   Şahiner, Levent ^a   Kaya, Ergün Bariş ^a   Aytemir, Kudret ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

atrial fibrillation; atrial fibrosis; catheter ablation; cryoablation; magnetic resonance imaging; transforming growth factor (TGF 1)

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRYOABLATION; DELAYED ENHANCED MAGNETIC RESONANCE IMAGING; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CYCLE; HEART ELECTROPHYSIOLOGY; HEART LEFT ATRIUM FIBROSIS; HEART MUSCLE FIBROSIS; HEART RATE; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RR INTERVAL; SINUS RHYTHM; ATRIAL FIBRILLATION; BLOOD; CARDIOMYOPATHIES; CRYOSURGERY; FIBROSIS; HEART ATRIUM; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME;

ADULT; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; CATHETER ABLATION; CRYOSURGERY; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME;

EID: 84924621158     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12578     Document Type: Article

References (21)

1. Andrade JG, Khairy P, Guerra PG, Deyell MW, Rivard L, Macle L, Thibault B, Talajic M, Roy D, Dubuc M,: Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published studies. Heart Rhythm 2011; 8: 1444-1451.
2. Oto A, Aytemir K, Canpolat U, Karakulak U, Evranos B, Sahiner L, Okutucu S, Kaya EB, Tokgozoglu L, Kabakci G,: Pulmonary vein isolation with the cryoballoon technique in atrial fibrillation treatment: Single centre experience. Turk Kardiyol Dern Ars 2013; 41: 299-309.
3. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D,: 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14: 528-606.
4. Kottkamp H,: Fibrotic atrial cardiomyopathy: A specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J Cardiovasc Electrophysiol 2012; 23: 797-799.
5. Burstein B, Nattel S,: Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809.
6. Wu CH, Hu YF, Chou CY, Lin YJ, Chang SL, Lo LW, Tuan TC, Li CH, Chao TF, Chung FP, Liao JN, Chen SA,: Transforming growth factor-beta1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation. Heart Rhythm 2013; 10: 10-15.
7. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF,. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009; 119: 1758-1767.
8. Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CT, McGann CJ, Akoum N, Kholmovski E, Macleod RS, Marrouche NF,: Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: Implications for disease progression and response to catheter ablation. Heart Rhythm 2010; 7: 1475-1481.
9. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH,: Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-1420.
10. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL,: The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987; 317: 669-674.
11. Hsu LY, Ingkanisorn WP, Kellman P, Aletras AH, Arai AE,: Quantitative myocardial infarction on delayed enhancement MRI. Part II: Clinical application of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006; 23: 309-314.
12. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J,: Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: The DECAAF study. JAMA 2014; 311: 498-506.
13. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S,: Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 2005; 7: 775-782.
14. Aytemir K, Oto A, Canpolat U, Sunman H, Yorgun H, Sahiner L, Kaya EB,: Immediate and medium-term outcomes of cryoballoon-based pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation: Single-centre experience. J Interv Card Electrophysiol 2013; 38: 187-195.
15. Allessie M, Ausma J, Schotten U,: Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54: 230-46.
16. Levy S,: Factors predisposing to the development of atrial fibrillation. Pacing Clin Electrophysiol 1997; 20: 2670-2674.
17. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A,: Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-1184.
18. Stiles MK, John B, Wong CX, Kuklik P, Brooks AG, Lau DH, Dimitri H, Roberts-Thomson KC, Wilson L, De Sciscio P, Young GD, Sanders P,: Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: Characterizing the "second factor." J Am Coll Cardiol 2009; 53: 1182-1191.
19. Kim SK, Park JH, Kim JY, Choi JI, Joung B, Lee MH, Kim SS, Kim YH, Pak HN,: High plasma concentrations of transforming growth factor-beta and tissue inhibitor of metalloproteinase-1: Potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation. Circ J 2011; 75: 557-564.
20. Thomas SP, Lim TW, McCall R, Seow SC, Ross DL,: Electrical isolation of the posterior left atrial wall and pulmonary veins for atrial fibrillation: Feasibility of and rationale for a single-ring approach. Heart Rhythm 2007; 4: 722-730.
21. Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S, Badger T, Burgon N, Haslam T, Kholmovski E, Macleod R, Marrouche N,: Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: A DE-MRI guided approach. J Cardiovasc Electrophysiol 2011; 22: 16-22.